
Article 1 
The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.
Article 2 
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
It shall apply from 17 February 2015.
This Regulation shall be binding in its entirety and directly applicable in all Member States.Done at Brussels, 18 December 2014
For the Commission
The President
Jean-Claude JUNCKER
ANNEX

In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance tulathromycin is replaced by the following:

Pharmacologically active Substance Marker residue Animal Species MRL Target Tissues Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009) Therapeutic classification
‘Tulathromycin (2R,3S,4R,5R,8R,10R,11R,12S, 13S,14R)-2-ethyl-3,4,10,13-tetra-hydroxy-3,5,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethy-lamino)-ß-D-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopent-decan-15-one expressed as tulathromycin equivalents Bovine 300 μg/kg200 μg/kg4 500 μg/kg3 000 μg/kg MuscleFatLiverKidney Not for use in animals from which milk is produced for human consumptionProvisional MRLs expire on 1 January 2015 Anti-infectious agents/Antibiotics’
Porcine 800 μg/kg300 μg/kg4 000 μg/kg8 000 μg/kg MuscleSkin and fat in natural proportionsLiverKidney Provisional MRLs expire on 1 January 2015
